Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Stem Cell Research & Therapy|June 14, 2018
Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cellsDewan Zhao, Lingjia Liu, Qiang Chen, et al.
British Journal of Haematology|October 2, 2018
SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemiaPan Zhao, Jingcao Huang, Dan Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 8, 2021
Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow HomingYing Qu, Bingyang Chu, Xue Wei, et al.
Breast Cancer Research : BCR|October 31, 2013
Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancerShuiliang Wang, Jingcao Huang, Hui Lyu, et al.
American Journal of Cancer Research|July 11, 2022
Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemiaYang Dai, Jingcao Huang, Pu Kuang, et al.
Biomarker Research|October 15, 2021
Minimal residual disease in multiple myeloma: current statusHong Ding, Juan Xu, Zhimei Lin, et al.
American Journal of Translational Research|September 15, 2022
A novel immune prognostic model of non-M3 acute myeloid leukemiaHong Ding, Yu Feng, Juan Xu, et al.
Bone|February 8, 2018
Young female patients with multiple myeloma have low occurrence of osteolytic lesionDanfeng Zhang, Jingcao Huang, Wenyan Zhang, et al.
Cell Death & Disease|August 8, 2025
Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathwayQing Li, Fangfang Wang, Xinrong Xiang, et al.
Cell Death & Disease|August 13, 2024
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomibYu Feng, Hongmei Luo, Jingcao Huang, et al.
Pageof 5